MediciNova Overview
- Founded
- 2000
- Status
- Public
- Employees
- 8
- Stock Symbol
- MNOV
- Investments
- 1
- Share Price
- $6.54
- (As of Thursday Closing)
MediciNova General Information
Description
MediciNova Inc is a biopharmaceutical company. It acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases. It has the acquisition and development of small molecule therapeutics segment.
Contact Information
Primary Industry
Pharmaceuticals
Other Industries
Therapeutic Devices
Drug Discovery
Stock Exchange
NAS
Primary Office
- 4275 Executive Square
- Suite 650
- San Diego, CA 92037
- United States
+1 (858) 000-0000
MediciNova Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $6.54 | $6.72 | $2.79 - $13.25 | $290M | 44.4M | 1.6M | -$0.25 |
MediciNova Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
|---|---|---|---|---|
| EV | 177,518 | 232,622 | 279,728 | 209,036 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (12,316) | (14,053) | (15,584) | (13,025) |
| Net Income | (11,527) | (12,942) | (14,675) | (11,163) |
| Total Assets | 75,838 | 79,205 | 77,223 | 43,419 |
| Total Debt | 0 | 0 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
MediciNova Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore MediciNova‘s full profile, request access.
Request a free trialMediciNova Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
This information is available in the PitchBook Platform. To explore MediciNova‘s full profile, request access.
Request a free trialMediciNova Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
MediciNova Inc is a biopharmaceutical company. It acquires and develops small-molecule therapeutics for the treatment of
Pharmaceuticals
San Diego, CA
8
As of 2019
00000
00000000000
00000
0000000
piscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ve
000000000000000
East Rutherford, NJ
0000
As of 0000
0.00
0000-00-00
000000000000
00000
aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. E
0000 000000000
Mumbai, India
00000
As of 0000
00000000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialMediciNova Competitors (21)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cambrex | Private Equity-Backed | East Rutherford, NJ | 0000 | 000000000000 | ||
| 00000 | Corporation | Mumbai, India | 00000 | 00000000 | ||
| 0000000000 0000000 | Corporation | San Francisco, CA | 000 | 000000&0 | ||
| 0000 00000000 | Formerly VC-backed | Stamford, CT | 00 | 00000 | 000000&0 | 00000 |
| 000000 | Formerly VC-backed | Loos, France | 000 | 00000 | 000000000. 0 | 00000 |
MediciNova Executive Team (11)
MediciNova Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| David O'Toole | Self | Board Member | 000 0000 |
| Kazuko Matsuda Ph.D | MediciNova | Chief Medical Officer & Board Member | 000 0000 |
| Yutaka Kobayashi | Self | Board Member | 000 0000 |
MediciNova Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialMediciNova Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 | 18-Dec-2009 | 000000000000000000 | 0000 | Biotechnology | 000000 00000 00 |